Zhixin Cao

Mr. Zhixin Cao


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 March 2026 in Applied Health Economics and Health Policy
Verified
Journal Article
Open access
PDF file
DYDanwei Yang
Danwei Yang
ZCZhixin Cao
Zhixin Cao
JBJayoung Byun
Jayoung Byun
JBJong-Wook Ban
Jong-Wook Ban
DKDavid D. Kim
David D. Kim
Background Microsimulation models are increasingly used to project health trajectories of individuals with cardiometabolic diseases, including type 2 diabetes, obesity, cardiovascular disease, and chronic kidney disease. Despite the emergence of practice guidelines on model calibration and validation, it remains unclear whether practices in model development and reporting have improved accordingly. Objective To summarize the characteristics of studies reporting cardiometabolic disease microsimulation models, assess how calibration and validation processes are reported, and examine variations in reporting practices by study characteristics. Methods We searched PubMed, Embase, and Web of Science for studies reporting the original development of microsimulation models of cardiometabolic diseases published between 2016 and June 1, 2024. Studies reporting calibration and/or validation processes were included. We recorded study characteristics and assessed reporting adherence to six calibration processes (defining parameters, selecting targets, applying search strategies, specifying convergence criteria, establishing stopping rules, and selecting goodness-of-fit measures) and five validation processes (face validity, verification, cross-validation, external validation, and predictive validation) based on published practice guidelines. We further investigated variation in guideline adherence by study characteristics (modeling type, cardiometabolic diseases, publication year, baseline population data source, modeling country, simulation tool, and open-source status). This study is registered in PROSPERO (CRD42024562800). Results Of 2646 studies screened, 31 were included in the final sample. Sixteen studies (52%) reported application-based model development and 15 (48%) reported natural history model development; 7 (23%) made their code publicly available; and 8 (26%) simulated three or more diseases. For calibration, 23 studies (74%) reported at least one of the six processes, most often specifying calibration targets (n = 22, 71%) and calibrated parameters (n = 21, 68%). For validation, 26 studies (84%) reported at least one of the five processes, most commonly external validation (n = 19, 61%), but no study reported predictive validation. Studies that developed natural history models more often reported goodness-of-fit measures, stopping rules, and external validation than application-based models. Studies that open-sourced their code reported statistical goodness-of-fit measures more frequently than those that did not. Models simulating three or more diseases more often documented face validity and verification than those simulating fewer diseases. Conclusions Reporting of calibration and validation in recent microsimulation models has improved, but important gaps remain. We suggest that future work prioritize (1) more rigorous calibration and validation in application-based model development, (2) clearer reporting of calibration processes, particularly parameter search strategies and convergence criteria, (3) stronger quantitative performance measures for external validation and greater use of predictive validation, and (4) broader adoption of open-source practices to enhance transparency and reproducibility.

25 December 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
ZCZhixin Cao
Zhixin Cao
YFYue Fang
Yue Fang
CWChenyu Wang
Chenyu Wang
RARuopeng An
Ruopeng An
Background/Objectives: Obesity is a major global public health and economic challenge. Governments worldwide have implemented nutrition-focused policies such as sugar-sweetened beverage taxes, front-of-pack labeling, food assistance reforms, and school nutrition standards to improve diet quality and reduce obesity. Because large-scale randomized controlled trials are often infeasible and conventional epidemiologic methods overlook population heterogeneity and behavioral feedback, microsimulation modeling has become a key tool for evaluating long-term and distributional policy impacts. This scoping review examined the application of microsimulation to obesity-related nutrition policies, focusing on model structure, behavioral parameterization, and integration of economic and equity analyses. Methods: Following PRISMA guidelines (PROSPERO CRD42024599769), five databases were searched for peer-reviewed studies. Data were extracted on policy mechanisms, model design, parameterization, and equity analysis. Study quality was assessed using a customized 21-item checklist adapted from CHEERS and NIH tools. Results: Twenty-nine studies met the inclusion criteria, with most policy settings based in the United States. Most employed dynamic, stochastic, individual-level microsimulation models with diverse behavioral assumptions, obesity equations, and calibration approaches. While most studies stratified outcomes by socioeconomic or demographic group, only one used a formal quantitative equity metric. Conclusions: Microsimulation modeling provides valuable evidence on the long-term health, economic, and distributional impacts of nutrition policies. Future work should strengthen methodological transparency, standardize equity assessment, and expand application beyond high-income settings to improve the comparability, credibility, and policy relevance of simulation-based nutrition policy research.